TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,334,000 | +202.4% | 110,748 | +7.9% | 0.23% | +258.5% |
| Q1 2022 | $2,756,000 | +166.3% | 102,642 | +373.0% | 0.06% | +195.5% |
| Q4 2021 | $1,035,000 | -9.4% | 21,698 | +26.1% | 0.02% | -15.4% |
| Q3 2021 | $1,143,000 | -4.1% | 17,211 | +12.7% | 0.03% | 0.0% |
| Q2 2021 | $1,192,000 | -20.9% | 15,272 | -4.1% | 0.03% | -13.3% |
| Q1 2021 | $1,507,000 | -29.1% | 15,930 | -8.7% | 0.03% | -37.5% |
| Q4 2020 | $2,127,000 | +38.1% | 17,455 | -1.0% | 0.05% | +9.1% |
| Q3 2020 | $1,540,000 | +34.1% | 17,629 | -0.8% | 0.04% | +33.3% |
| Q2 2020 | $1,148,000 | +45.7% | 17,768 | +0.7% | 0.03% | +13.8% |
| Q1 2020 | $788,000 | -17.2% | 17,646 | +15.5% | 0.03% | +26.1% |
| Q4 2019 | $952,000 | +64.1% | 15,284 | -0.9% | 0.02% | +64.3% |
| Q3 2019 | $580,000 | – | 15,422 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |